Những nghiên cứu mới về vắc-xin (Cập nhật đến ngày 4/8/2023)
Cập nhật vào: Thứ sáu - 04/08/2023 01:01 Cỡ chữ
Cục Thông tin khoa học và công nghệ quốc gia trân trọng kính gửi đến các nhà khoa học những nghiên cứu mới nhất về vaccine COVID-19 trên thế giới. Bao gồm những bài viết đã được xuất bản chính thức và các bài viết được chấp nhận đăng trên những cơ sở dữ liệu học thuật chính thống cập nhật đến ngày 04/8/2023.
1. Sciencedirect
1. Licenced doses of approved COVID-19 vaccines may not be optimal: A review of the early-phase, dose-finding trials
Vaccine Available online 16 June 2023 In press, corrected proof
David T. Dunn, Richard Gilson, Laura E. McCoy
https://www.sciencedirect.com/science/article/pii/S0264410X23007120/pdfft?md5=aee532d0ba1fa11971eff83c057e1713&pid=1-s2.0-S0264410X23007120-main.pdf
2. Misinformation and COVID-19 vaccine hesitancy
Vaccine 14 November 2022 Volume 41, Issue 1 (Cover date: 4 January 2023) Pages 136-144
Tara Zimmerman, Kristina Shiroma, Min Kyung Lee
https://www.sciencedirect.com/science/article/pii/S0264410X22014025/pdfft?md5=3d15c8a9cccef081fc3ec4892f93fbe9&pid=1-s2.0-S0264410X22014025-main.pdf
3. COVID-19 vaccine hesitancy and racial discrimination among US adults
Preventive Medicine Reports 28 November 2022 Volume 31 (Cover date: February 2023) Article 102074
Don E. Willis, Brooke E. E. Montgomery, Pearl A. McElfish
https://www.sciencedirect.com/science/article/pii/S2211335522003813/pdfft?md5=95c4c96617004744d809b43608b14a68&pid=1-s2.0-S2211335522003813-main.pdf
4. COVID-19 vaccine provocation test outcome in high-risk allergic patients: A retrospective study from a tertiary hospital in Indonesia
World Allergy Organization Journal 13 December 2022 Volume 16, Issue 1 (Cover date: January 2023) Article 100734
Sukamto Koesnoe, Suzy Maria, Evy Yunihastuti
https://www.sciencedirect.com/science/article/pii/S1939455122001107/pdfft?md5=36cea3468bcbefc5b7b8e060fb9ba18a&pid=1-s2.0-S1939455122001107-main.pdf
5. Exploring the Intention and Hesitancy to Receive a Booster Dose of COVID-19 Vaccine among Patients with Comorbid Disease Conditions Using a Health Belief Model.
Vacunas Available online 29 June 2023 In press, journal pre-proof
Anmar AL-TAIE, Zekiye K. YILMAZ
https://www.sciencedirect.com/science/article/pii/S1576988723000560/pdfft?md5=d3aefaf67debbc887f427846443ca254&pid=1-s2.0-S1576988723000560-main.pdf
6. Attitudes toward COVID-19 vaccine mandate: The role of psychological characteristics and partisan self-identification
Personality and Individual Differences 9 February 2023 Volume 206 (Cover date: May 2023) Article 112119
Filip Viskupič, David L. Wiltse, Alper Kayaalp
https://www.sciencedirect.com/science/article/pii/S0191886923000429/pdfft?md5=5eae777922585f02ce1232a5f74515d2&pid=1-s2.0-S0191886923000429-main.pdf
7. Views and perceptions of the public toward COVID-19 vaccine in Saudi Arabia
Saudi Pharmaceutical Journal 8 May 2023 Volume 31, Issue 6 (Cover date: June 2023) Pages 942-947
Abrar K. Thabit, Aisha F. Badr, Ghuna Al-Saudi
https://www.sciencedirect.com/science/article/pii/S1319016423001214/pdfft?md5=43001fb4951d1b3688f65a6868631235&pid=1-s2.0-S1319016423001214-main.pdf
8. Prevalence of COVID-19 vaccine acceptance among migrant and refugee groups: A systematic review and meta-analysis
Vaccine: X 6 May 2023 Volume 14 (Cover date: August 2023) Article 100308
Zainab Alimoradi, Malik Sallam,Amir H. Pakpour
https://www.sciencedirect.com/science/article/pii/S2590136223000499/pdfft?md5=5d7fa330d92bd46270392b4b714d47d7&pid=1-s2.0-S2590136223000499-main.pdf
9. Role of perceived social support in COVID-19 vaccine uptake among U.S. adults
AJPM Focus Available online 27 April 2023 In press, journal pre-proof Article 100104
Biplab Kumar Datta, Jennifer E. Jaremski, J. Aaron Johnson
https://www.sciencedirect.com/science/article/pii/S277306542300041X/pdfft?md5=b489b71695b98f8ff4f04c92d9a7b5e2&pid=1-s2.0-S277306542300041X-main.pdf
10. Safety and efficacy of the two doses conjugated protein-based SOBERANA-02 COVID-19 vaccine and of a heterologous three-dose combination with SOBERANA-Plus: a double-blind, randomised, placebo-controlled phase 3 clinical trial
The Lancet Regional Health - Americas 31 December 2022 Volume 18 (Cover date: February 2023) Article 100423
María Eugenia Toledo-Romaní, Mayra García-Carmenate, Vicente Verez-Bencomo
https://www.sciencedirect.com/science/article/pii/S2667193X2200240X/pdfft?md5=ee3a6f28ec806affe80782b5aac50fc0&pid=1-s2.0-S2667193X2200240X-main.pdf
11. Monitoring the safety of drugs and COVID-19 vaccines by the French Pharmacovigilance Centers during the pandemic: A win-win bet with Health Authorities!
Therapies Available online 7 March 2023 In press, corrected proof
Annie Pierre Jonville-Bera, Sophie Gautier, Milou-Daniel Drici
https://www.sciencedirect.com/science/article/pii/S0040595723000501/pdfft?md5=7743a315890900112a4b09e111884b56&pid=1-s2.0-S0040595723000501-main.pdf
12. Development and validation of a multi-dimensional COVID-19 vaccine hesitancy questionnaire
Vaccine: X 23 March 2023 Volume 14 (Cover date: August 2023) Article 100286
Hamed Hammoud, Soha S. Albayat, Iheb Bougmiza
https://www.sciencedirect.com/science/article/pii/S259013622300027X/pdfft?md5=40b5c67ccf04985cb652cf9645de792e&pid=1-s2.0-S259013622300027X-main.pdf
13. Uptake of COVID-19 vaccines among healthcare workers and the effect of nudging interventions: A mixed methods study
Vaccine Available online 9 June 2023 In press, corrected proof
Bahar Madran, İlker Kayı, Önder Ergönül
https://www.sciencedirect.com/science/article/pii/S0264410X23006886/pdfft?md5=9ea35e3ef7bfab2317d05346d75e8014&pid=1-s2.0-S0264410X23006886-main.pdf
14. Robust SARS-CoV-2 T cell responses with common TCRαβ motifs toward COVID-19 vaccines in patients with hematological malignancy impacting B cells
Cell Reports Medicine 27 March 2023 Volume 4, Issue 4 (Cover date: 18 April 2023) Article 101017
Thi H. O. Nguyen, Louise C. Rowntree, Katherine Kedzierska
https://www.sciencedirect.com/science/article/pii/S2666379123001271/pdfft?md5=9490132aa1bd46e14e3f2e30ac2f4d8b&pid=1-s2.0-S2666379123001271-main.pdf
15. Safety profile of inactivated COVID-19 vaccine in indonesian adults
Vaccine: X 10 June 2023 Volume 14 (Cover date: August 2023) Article 100331
Hindra Irawan Satari, Nastiti Kaswandani, Putra Fajar Angkasa
https://www.sciencedirect.com/science/article/pii/S2590136223000724/pdfft?md5=4574e87019663ca11d72805f986dda5d&pid=1-s2.0-S2590136223000724-main.pdf
16. Dengue vaccine acceptability before and after the availability of COVID-19 vaccines in Puerto Rico
Vaccine 5 May 2023 Volume 41, Issue 24 (Cover date: 1 June 2023) Pages 3627-3635
Dania M. Rodriguez, Chelsea G. Major, Laura E. Adams
https://www.sciencedirect.com/science/article/pii/S0264410X23005169/pdfft?md5=b3f351c0199fb56868da68331ac106c5&pid=1-s2.0-S0264410X23005169-main.pdf
17. COVID-19 vaccine hesitancy among health workers in rural Uganda: A mixed methods study
Vaccine: X 7 January 2023 Volume 13 (Cover date: April 2023) Article 100260
Patrick Diox Ouni, Racheal Namulondo, David Mukunya
https://www.sciencedirect.com/science/article/pii/S2590136223000013/pdfft?md5=1022adfdf10e43c54482ed46c99eba21&pid=1-s2.0-S2590136223000013-main.pdf
18. Vaccine Attitudes and COVID-19 Vaccine Intention Among Parents of Children With Kidney Disease or Primary Hypertension
American Journal of Kidney Diseases 21 June 2022 Volume 81, Issue 1 (Cover date: January 2023) Pages 25-35.e1
Chia-shi Wang, Rinchen Doma, Robert A. Bednarczyk
https://www.sciencedirect.com/science/article/pii/S027263862200720X/pdfft?md5=e2894685eaf84b0eb4a5a854ecad973d&pid=1-s2.0-S027263862200720X-main.pdf
19. Results from a preclinical study in rodents and a Phase 1/2, randomized, double-blind, placebo-controlled, parallel-group study of COVID-19 vaccine S-268019-a in Japanese adults
Vaccine 16 December 2022 Volume 41, Issue 11 (Cover date: 10 March 2023) Pages 1834-1847
Takuhiro Sonoyama, Satoshi Iwata, Mari Ariyasu
https://www.sciencedirect.com/science/article/pii/S0264410X22015407/pdfft?md5=029a66c97d37022274ef5aa5f3b56135&pid=1-s2.0-S0264410X22015407-main.pdf
20. Safety of inactivated COVID-19 vaccines in autoimmune encephalitis: A real-world cross-sectional survey
Multiple Sclerosis and Related Disorders 30 December 2022 Volume 70 (Cover date: February 2023) Article 104495
Xu Liu, Kundian Guo, Zhen Hong
https://www.sciencedirect.com/science/article/pii/S2211034822009993/pdfft?md5=0253990c90b6b83e5683dd0dd11867fc&pid=1-s2.0-S2211034822009993-main.pdf
21. Key factors influencing paediatric COVID-19 vaccine hesitancy: a brief overview and Decision-making Trial and Evaluation Laboratory analysis
Public Health 28 November 2022 Volume 218 (Cover date: May 2023) Pages 97-105
Y. Wang, X. Zhang
https://www.sciencedirect.com/science/article/pii/S0033350622003316/pdfft?md5=920c3850f395037cd60c531142799427&pid=1-s2.0-S0033350622003316-main.pdf
22. From COVID-19 vaccine candidates to compulsory vaccination: The attitudes of Italian citizens in the key 7-month of vaccination campaign
Vaccine 3 March 2023 Volume 41, Issue 15 (Cover date: 6 April 2023) Pages 2582-2588
Andrea Grignolio Corsini, Roberta Martina Zagarella, Cinzia Caporale
https://www.sciencedirect.com/science/article/pii/S0264410X23002438/pdfft?md5=68a501f40f26f9f9dcc5c1986abd40fb&pid=1-s2.0-S0264410X23002438-main.pdf
23. Instilling Confidence in the COVID-19 Vaccine
Nursing Clinics of North America 7 November 2022 Volume 58, Issue 1 (Cover date: March 2023) Pages 77-85
Kristine Gonnella, Deepa Mankikar
https://www.sciencedirect.com/science/article/pii/S0029646522033849/pdfft?md5=cc76b3e9b0b0dc0d81c1280e4fc70dba&pid=1-s2.0-S0029646522033849-main.pdf
24. mRNA versus inactivated virus COVID-19 vaccines in multiple sclerosis: Humoral responses and protectivity—Does it matter?
Multiple Sclerosis and Related Disorders 10 May 2023 Volume 75 (Cover date: July 2023) Article 104761
Melih Tütüncü, Serkan Demir, Aksel Siva
https://www.sciencedirect.com/science/article/pii/S2211034823002596/pdfft?md5=51bc0ea3699f9d543b32b48504c97a15&pid=1-s2.0-S2211034823002596-main.pdf
25. Examining confidence and hesitancy towards COVID-19 vaccines: A cross-sectional survey using in-person data collection in rural Ghana
Vaccine 13 February 2023 Volume 41, Issue 13 (Cover date: 24 March 2023) Pages 2113-2119
OK Afreh, P Angwaawie, GAA Vidzro
https://www.sciencedirect.com/science/article/pii/S0264410X23001597/pdfft?md5=1fa1a7744f19fd76ced68994f6bdb62d&pid=1-s2.0-S0264410X23001597-main.pdf
26. Update on the effectiveness of COVID-19 vaccines on different variants of SARS-CoV-2
International Immunopharmacology 2 March 2023 Volume 117 (Cover date: April 2023) Article 109968
Negar Firouzabadi, Parisa Ghasemiyeh, Soliman Mohammadi-Samani
https://www.sciencedirect.com/science/article/pii/S1567576923002898/pdfft?md5=2c67c54c5e558d26d444ba5cb7c08c20&pid=1-s2.0-S1567576923002898-main.pdf
27. Evaluation of non-clinical toxicity studies of COVID-19 vaccines
Regulatory Toxicology and Pharmacology Available online 23 June 2023 In press, journal pre-proof Article 105438
N. K. M. Schilder, B. Tiesjema, J. W. van der Laan
https://www.sciencedirect.com/science/article/pii/S027323002300106X/pdfft?md5=59da29da58dd25f8d33ee812eb04bb1f&pid=1-s2.0-S027323002300106X-main.pdf
28. Effectiveness of heterologous third and fourth dose COVID-19 vaccine schedules for SARS-CoV-2 infection during delta and omicron predominance in Thailand: a test-negative, case-control study
The Lancet Regional Health - Southeast Asia 29 November 2022 Volume 10 (Cover date: March 2023) Article 100121
Kannikar Intawong, Suwat Chariyalertsak, Sopon Iamsirithaworn
https://www.sciencedirect.com/science/article/pii/S277236822200138X/pdfft?md5=a87b394145b36928da1bf648d6f49c6e&pid=1-s2.0-S277236822200138X-main.pdf
29. Reducing barriers to COVID-19 vaccine uptake through a culturally sensitive pharmacy-led patient medication education group in a behavioral health population
Journal of the American Pharmacists Association 27 January 2023 Volume 63, Issue 3 (Cover date: May–June 2023) Pages 915-919
Ina Liu, Aliyah Cruz, Suzanne C. Harris
https://www.sciencedirect.com/science/article/pii/S1544319123000134/pdfft?md5=4d8a5797753cc0874a821cce33c4537f&pid=1-s2.0-S1544319123000134-main.pdf
30. Neutralizing antibodies and T-cell responses to inactivated SARS-CoV-2 vaccine in COVID-19 convalescents one and a half years after infection
Virus Research 22 October 2022 Volume 323 (Cover date: 2 January 2023) Article 198977
Li-Na Yan, Dan Li, Xue-Jie Yu
https://www.sciencedirect.com/science/article/pii/S0168170222003069/pdfft?md5=7b02b2a4a35ba39e4eaa25be61ff82cd&pid=1-s2.0-S0168170222003069-main.pdf
31. Herding behavior in COVID-19 vaccine hesitancy in rural Zimbabwe: The moderating role of health information under heterogeneous household risk perceptions
Social Science & Medicine 17 March 2023 Volume 323 (Cover date: April 2023) Article 115854
Terrence Kairiza, George Kembo, Lloyd Chigusiwa
https://www.sciencedirect.com/science/article/pii/S0277953623002113/pdfft?md5=5dd9fd4ee3cef8e14943cc0d7c867fbf&pid=1-s2.0-S0277953623002113-main.pdf
32. Association between caregiver opposition to topical fluoride and COVID-19 vaccines
Vaccine 14 December 2022 Volume 41, Issue 5 (Cover date: 27 January 2023) Pages 1035-1041
Sapna J. Saini, Adam C. Carle, Donald L. Chi
https://www.sciencedirect.com/science/article/pii/S0264410X22015328/pdfft?md5=80d9edf8f3a3360f6e03dee35b8eb2cd&pid=1-s2.0-S0264410X22015328-main.pdf
33. Psychometric development of the COVID-19 vaccine misinformation scale and effects on vaccine hesitancy
Preventive Medicine Reports 6 December 2022 Volume 31 (Cover date: February 2023) Article 102087
Stephen Bok, Daniel Martin, Maria Lee
https://www.sciencedirect.com/science/article/pii/S2211335522003941/pdfft?md5=cc1b22db1a4c49f276e148f15aadb27d&pid=1-s2.0-S2211335522003941-main.pdf
34. Disparities in COVID-19 vaccine hesitancy among a diverse community-based sample in Connecticut, United States
Preventive Medicine Reports 24 May 2023 Volume 34 (Cover date: August 2023) Article 102263
William H. Eger, Sakinah C. Suttiratana, Beth A. Jones
https://www.sciencedirect.com/science/article/pii/S2211335523001547/pdfft?md5=c83527cb9ec3b38a5dedfede85e89725&pid=1-s2.0-S2211335523001547-main.pdf
35. Socioeconomic status and disparities in COVID-19 vaccine uptake in Eastern Oslo, Norway
Public Health in Practice 28 May 2023 Volume 5 (Cover date: June 2023) Article 100391
Andreas Lillebråten, Megan Todd, Svenn-Erik Mamelund
https://www.sciencedirect.com/science/article/pii/S266653522300037X/pdfft?md5=93ee8df473f11f686e9cc41bd5a0beb7&pid=1-s2.0-S266653522300037X-main.pdf
36. Safety of the NVX-CoV2373 COVID-19 vaccine in randomized placebo-controlled clinical trials
Vaccine 10 May 2023 Volume 41, Issue 26 (Cover date: 13 June 2023) Pages 3930-3936
Katherine Smith, Karim Hegazy, Katia Alves
https://www.sciencedirect.com/science/article/pii/S0264410X23005431/pdfft?md5=38cce61480aa9a04d4e75830e5c74279&pid=1-s2.0-S0264410X23005431-main.pdf
37. Effectiveness of mRNA and inactivated COVID-19 vaccines: A test-negative study in an infection-naïve Hong Kong population
Journal of Infection Available online 26 May 2023 In press, corrected proof
Rita W. Y. Ng, Ryan K. H. Sze, Paul K. S. Chan
https://www.sciencedirect.com/science/article/pii/S0163445323002980/pdfft?md5=e790951e6bc1a08045d90493b6906de3&pid=1-s2.0-S0163445323002980-main.pdf
38. Racial and ethnic disparities in COVID-19 vaccine uptake: A mediation framework
Vaccine 1 March 2023 Volume 41, Issue 14 (Cover date: 31 March 2023) Pages 2404-2411
Ling Na, Sativa Banks, Peizhong Peter Wang
https://www.sciencedirect.com/science/article/pii/S0264410X23002414/pdfft?md5=8b64e376f582f88c690d8c1d92e11618&pid=1-s2.0-S0264410X23002414-main.pdf
39. Technology targeting immunocompromised patients for COVID-19 vaccine in community pharmacies
Research in Social and Administrative Pharmacy 2 December 2022 Volume 19, Issue 4 (Cover date: April 2023) Pages 610-614
Grace E. La, FleurAndrew G. Azzi, Mitchell S. Howard
https://www.sciencedirect.com/science/article/pii/S1551741122004156/pdfft?md5=141b60d61922611acb66d0f84dc9d0ea&pid=1-s2.0-S1551741122004156-main.pdf
40. Persistence of immune responses after heterologous and homologous third COVID-19 vaccine dose schedules in the UK: eight-month analyses of the COV-BOOST trial
Journal of Infection 20 April 2023 Volume 87, Issue 1 (Cover date: July 2023) Pages 18-26
Xinxue Liu, Alasdair P S Munro, Saul N Faust
https://www.sciencedirect.com/science/article/pii/S0163445323002475/pdfft?md5=1dc54b3340cea272a4dab000be568e84&pid=1-s2.0-S0163445323002475-main.pdf
41. Background rates of 41 adverse events of special interest for COVID-19 vaccines in 10 European healthcare databases - an ACCESS cohort study
Vaccine 22 November 2022 Volume 41, Issue 1 (Cover date: 4 January 2023) Pages 251-262
C Willame, C Dodd, MCJM Sturkenboom
https://www.sciencedirect.com/science/article/pii/S0264410X22014293/pdfft?md5=bbbb4d2b1ce4134d08a6f1267ba89fe3&pid=1-s2.0-S0264410X22014293-main.pdf
42. Safety of monovalent and bivalent BNT162b2 mRNA COVID-19 vaccine boosters in at-risk populations in Israel: a large-scale, retrospective, self-controlled case series study
The Lancet Infectious Diseases Available online 20 June 2023 In press, corrected proof
Dan Yamin, Matan Yechezke, lErez Shmueli
https://www.sciencedirect.com/science/article/pii/S1473309923002074/pdfft?md5=b9dbe79bb12120645069898c4133c253&pid=1-s2.0-S1473309923002074-main.pdf
43. Futile or fertile? The effect of persuasive strategies on citizen engagement in COVID-19 vaccine-related tweets across six national health departments
Social Science & Medicine 5 December 2022 Volume 317 (Cover date: January 2023) Article 115591
Di Wang, Jiahui Lu, Ying Zhong
https://www.sciencedirect.com/science/article/pii/S0277953622008978/pdfft?md5=82aa5403fa6080fafe6003c53098b41f&pid=1-s2.0-S0277953622008978-main.pdf
44. Methodological changes implemented over time to support accurate and timely COVID-19 vaccine coverage estimates: Ontario, Canada
Vaccine 7 April 2023 Volume 41, Issue 21 (Cover date: 16 May 2023) Pages 3328-3336
J. Leigh Hobbs, Lauren A. Paul, Sarah E. Wilson
https://www.sciencedirect.com/science/article/pii/S0264410X23003894/pdfft?md5=056b57a414406ca9e58e8504afd7d9ff&pid=1-s2.0-S0264410X23003894-main.pdf
Nguồn: Cục Thông tin khoa học và công nghệ quốc gia, 4/8/2023